Cancers after renal transplantation: multicenter experience

Area of Science:

• Nephrology
• Oncology
• Immunology

Background:

• Renal transplant recipients have a higher incidence of specific cancers, including lymphomas and skin cancers, compared to the general and dialysis populations.
• Immunosuppressive therapy is essential for graft survival but increases cancer risk.

Purpose of the Study:

• To investigate the prevalence and characteristics of tumors in adult renal transplant recipients.
• To identify risk factors and outcomes associated with post-transplant cancers.

Main Methods:

• Retrospective study of 36 adult renal transplant recipients across four Tunisian centers from January 1986 to January 2005.
• Analysis of patient demographics, transplantation details, immunosuppressive regimens, tumor types, and patient outcomes.
• Review of cancer incidence, timing, and specific tumor histology.

Main Results:

• Cancer incidence was 7%, occurring a mean of 54 months post-transplantation.
• Solid tumors (83%) included Kaposi sarcoma (41.6%) and lymphomas (27.7%). Skin tumors (17%) were predominantly spinocellular carcinoma (83%).
• Mortality was 33.3%, while 55.5% experienced cancer regression after reducing immunosuppression; switching to sirolimus showed favorable outcomes.

Conclusions:

• Post-renal transplant cancer is characterized by a predominance of Kaposi sarcoma, linked to solar exposure and potent immunosuppression.
• Careful patient follow-up and timely intervention, including immunosuppression adjustment, can decrease cancer-related mortality.